Phase (Ph) I evaluation of the dolastatin analogue synthadotin (SYN-D; ILX651): Pooled data analysis of three alternate schedules in patients (pts) with advanced solid tumorsL. A. Hammond, Eric K. Rowinsky, J. Weiß et al.|Journal of Clinical Oncology|2004Cited by 8
Pharmacokinetics of synthadotin (ILX651), a novel tubulin polymerization inhibitor, in patients with solid tumorsPeter L. Bonate, L. A. Hammond, Scot Ebbinghaus et al.|Journal of Clinical Oncology|2004Cited by 2
Phase (Ph) I evaluation of the dolastatin analogue synthadotin (SYN-D; ILX651): Pooled data analysis of three alternate schedules in patients (pts) with advanced solid tumorsL. A. Hammond, Eric K. Rowinsky, F. Ruvuna et al.|Journal of Clinical Oncology|2004Cited by 1
Pharmacokinetics of synthadotin (ILX651), a novel tubulin polymerization inhibitor, in patients with solid tumorsPeter L. Bonate, L. A. Hammond, Elliot V. Hersh et al.|Journal of Clinical Oncology|2004Cited by 0